![Stephen Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Doyle
Corporate Officer/Principal bei
ASLAN PHARMACEUTICALS LIMITED
Profil
Stephen Doyle is currently Chief Business Officer at Aslan Pharmaceuticals Ltd. since 2019.
Formerly, Mr. Doyle was Chief Executive Officer at Qbiotics Group Ltd. from 2024 to 2025, Vice President & Head-Specialty Care China at Boehringer Ingelheim GmbH from 2014 to 2018, VP-Oncology, Hematology & Transplantation at Sanofi, Inc. (China) from 2010 to 2013, Commercial Director-Oncology at Sanofi-Aventis (Singapore) Pte Ltd. from 2007 to 2010, and Director & Head-Scientific Communications at Sanofi from 2005 to 2007.
Education includes a graduate degree from the University of Derby in 1998 and an undergraduate degree from The Robert Gordon University in 1994.
Aktive Positionen von Stephen Doyle
| Unternehmen | Position | Beginn |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01.02.2018 |
Ehemalige bekannte Positionen von Stephen Doyle
| Unternehmen | Position | Ende |
|---|---|---|
Qbiotics Group Ltd.
 Qbiotics Group Ltd. BiotechnologyHealth Technology Develops novel cell-signaling small molecules derived from natural sources for medical use | Vorstandsvorsitzender | 01.12.2025 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Corporate Officer/Principal | 01.01.2018 |
Sanofi, Inc. (China)
 Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for heart, kidney and diabetes problems | Corporate Officer/Principal | 01.10.2013 |
Sanofi-Aventis (Singapore) Pte Ltd.
 Sanofi-Aventis (Singapore) Pte Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare and pharmaceutical company that develops medicines and vaccines | Corporate Officer/Principal | 01.10.2010 |
| SANOFI | Corporate Officer/Principal | 01.11.2007 |
Ausbildung von Stephen Doyle
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Derby
 University of Derby Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Robert Gordon University
 The Robert Gordon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis (Singapore) Pte Ltd.
Sanofi-Aventis (Singapore) Pte Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare and pharmaceutical company that develops medicines and vaccines | Health Services |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Sanofi, Inc. (China)
Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for heart, kidney and diabetes problems | Health Technology |
Qbiotics Group Ltd.
Qbiotics Group Ltd. BiotechnologyHealth Technology Develops novel cell-signaling small molecules derived from natural sources for medical use | Health Technology |
